A homozygous protein-truncating mutation in ACTL7A causes male infertility characterized by fertilization failure
Reproductive and Developmental Medicine · 2022
DOI: 10.1097/rd9.0000000000000017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive and Developmental Medicine, 2022. Verfasst von Yao Chen und 5 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
This study aimed to screen for novel mutations in ACTL7A and expand the spectrum of known mutations responsible for recurrent fertilization failure.
Methods
Whole-exome sequencing was performed on samples from couples who experienced recurrent assisted reproductive technology failure and visited the General Hospital of Ningxia Medical University. Western blotting and quantitative Real-time PCR were used to investigate the effects of the mutation on HEK293T cells.
Results
Samples from 12 couples with total fertilization failure or poor fertilization (fertilization rate
Zitieren
APA
Chen, Y., Chen, B., Sang, Q., Wang, L., Zhao, J., & Sun, X. (2022). A homozygous protein-truncating mutation in ACTL7A causes male infertility characterized by fertilization failure. Reproductive and Developmental Medicine. https://doi.org/10.1097/rd9.0000000000000017
Vancouver
Chen Y, Chen B, Sang Q, Wang L, Zhao J, Sun X. A homozygous protein-truncating mutation in ACTL7A causes male infertility characterized by fertilization failure. Reproductive and Developmental Medicine. 2022. doi:10.1097/rd9.0000000000000017
BibTeX
@article{Chen2022,
author = {Chen, Yao and Chen, Biao-Bang and Sang, Qing and Wang, Lei and Zhao, Jun-Li and Sun, Xiao-Xi},
title = {A homozygous protein-truncating mutation in ACTL7A causes male infertility characterized by fertilization failure},
journal = {Reproductive and Developmental Medicine},
year = {2022},
doi = {10.1097/rd9.0000000000000017}
}
EUVIMED